Osprey’s mission is to prevent the high incidence of contrast-induced acute kidney injury (AKI) in cath lab patients. By decreasing the amount of contrast dye injected into patients without affecting image quality, our proprietary technologies allow uncompromised procedural efficiency and effectiveness, with significant AKI risk reduction.
Location: United States, Minnesota, Minnetonka
Employees: 11-50
Founded date: 2005
Investors 2
| Date | Name | Website |
| - | Talu Ventu... | taluventur... |
| - | Brandon Ca... | brandoncap... |
Mentions in press and media 4
| Date | Title | Description |
| 30.07.2020 | GE Healthcare to Distribute Osprey Medical’s Technology to Address Angiography Based Acute Kidney Injury (AKI) | GE Healthcare and Osprey Medical Inc. (ASX:OSP) (Osprey) today announced a strategic alliance under which GE Healthcare will exclusively distribute Osprey’s product portfolio in Europe, Russia, Middle East, Africa, Central Asia and Turkey. ... |
| 18.04.2012 | Analyst: Riata ruckus won’t hurt CRM market long-term | Wall Street Beat | The high-profile furor over St. Jude Medical‘s (NYSE:STJ) recalled Riata defibrillator leads last week won’t have a lasting impact on the overall cardiac rhythm management market, says Barclays Capital analyst Adam Feinstein. The CRM slump ... |
| 08.03.2012 | Kidney protection device firm to raise $21.2M in Australian public offering | Osprey Medical hopes to change that. “Current methods used for CIN prevention have had limited impact on reducing CIN risk and our initial data shows that the CINCOR System can reduce the risk of CIN by 50 percent,” said Mr Mike McCormick, ... |
| - | Kidney protection device firm to raise $21.2M in Australian public offering | A Minnesota medical device company whose products prevent kidneys from being affected from routine procedures related to angioplasty and stenting announced Thursday that it plans to raise more than $20 million by going public in an exchange... |